Patient info

Diprosalic 0.05% w/w / 3% w/w ointment – Summary of Product Characteristics (SmPC) for healthcare professionals

The Summary of Product Characteristics (SmPC) is written for healthcare professionals. Patients will find plain advice in the patient information leaflet: how to take, side effects, pregnancy and breast-feeding.

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
0.05% w/w / 3% w/w
Contains active substances:

Summary of Product Characteristics (SmPC) - Diprosalic 0.05% w/w / 3% w/w ointment

1 NAME OF THE MEDICINAL PRODUCT

Not applicable.

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Not applicable.

3 PHARMACEUTICAL FORM

Not applicable.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

Not applicable.

4.2 Posology and method of administration

Not applicable.

4.3 Contraindications

Not applicable.

4.4 Special warnings and precautions for use

Not applicable.

4.5 Interaction with other medicinal products and other forms of interaction

Not applicable.

4.6 Fertility, pregnancy and lactation

Not applicable.

4.7 Effects on ability to drive and use machines

Not applicable.

4.8 Undesirable effects

Not applicable.

4.9 Overdose

Not applicable.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not applicable.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Not applicable.

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

Not applicable.

6.4 Special precautions for storage

Not applicable.

6.5 Nature and contents of container

Not applicable.

6.6 Special precautions for disposal

Not applicable.

7 MARKETING AUTHORISATION HOLDER

Not applicable.

8 MARKETING AUTHORISATION NUMBER(S)

Not applicable.

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Not applicable.

10 DATE OF REVISION OF THE TEXT

04/09/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 19488/2003

Last revision stated in the text: 4 September 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Diprosalic 0.05% w/w / 3% w/w ointment

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Betamethasone, Salicylic acid
Strength 0.05% w/w / 3% w/w
Pharmaceutical form Cutaneous ointment
How is it taken Cutaneous
Excipients Not applicable.
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Not applicable.
Storage Not applicable.
Drug group (ATC)
  1. D Dermatologicals
    1. D07 Corticosteroids, dermatological preparations
      1. D07B Corticosteroids, combinations with antiseptics
        1. D07BC Corticosteroids, potent, combinations with antiseptics
          1. D07BC01 betamethasone and antiseptics
Marketing authorisation PLPI 19488/2003
Codes BNF 13040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.